Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1783300 | 1.00 | ALDH1A1 (0.38) | ALDH1A1LMNATDP1SLC15A2USP2 | |
| SCHEMBL22501042 | 0.83 | MAPT (0.45) | ALDH1A1LMNAUSP2MAPTRECQL | |
| SCHEMBL22501040 | 0.83 | MAPT (0.45) | ALDH1A1LMNAUSP2MAPTRECQL | |
| SCHEMBL1784356 | 0.77 | ALDH1A1 (0.36) | ALDH1A1LMNATDP1SLC15A2USP2 | |
| SCHEMBL1784355 | 0.77 | ALDH1A1 (0.36) | ALDH1A1LMNATDP1SLC15A2USP2 | |
| SCHEMBL11009268 | 0.75 | ALDH1A1 (0.56) | ALDH1A1LMNATDP1SLC15A2USP2 | |
| SCHEMBL11009265 | 0.75 | ALDH1A1 (0.56) | ALDH1A1LMNATDP1SLC15A2USP2 | |
| SCHEMBL24962942 | 0.75 | ALDH1A1 (0.35) | ALDH1A1LMNATDP1SLC15A2MAPT | |
| SCHEMBL1784893 | 0.75 | ALDH1A1 (0.35) | ALDH1A1TDP1CYP3A4MAPT | |
| SCHEMBL24311742 | 0.75 | ALDH1A1 (0.35) | ALDH1A1LMNATDP1SLC15A2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | ALDH1A1 520/4885LMNA 1708/4885TDP1 3995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.